Parathyroid hormone Subcutaneous and Ranibizumab ophthalmic
Determining the interaction of Parathyroid hormone Subcutaneous and Ranibizumab ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: parathyroid hormone
Brand name: Natpara
Synonyms: Parathyroid hormone, Parathyroid Hormone
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Parathyroid hormone Subcutaneous-Ranitidine
- Parathyroid hormone Subcutaneous-Ranitidine Capsule
- Parathyroid hormone Subcutaneous-Ranitidine Hydrochloride
- Parathyroid hormone Subcutaneous-Ranitidine Injection
- Parathyroid hormone Subcutaneous-Ranitidine Suspension
- Parathyroid hormone Subcutaneous-Ranitidine Syrup
- Ranibizumab ophthalmic-Parcopa
- Ranibizumab ophthalmic-Paregoric
- Ranibizumab ophthalmic-Paremyd
- Ranibizumab ophthalmic-Paremyd Ophthalmic
- Ranibizumab ophthalmic-Paricalcitol
- Ranibizumab ophthalmic-Paricalcitol Capsules